Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Sandu Pharmaceuticals Ltd

NSE: SANDUPHQ · BSE: 524703 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹37.00
Market cap: ₹35.75 Cr
Revenue (annual): ₹69.93 Cr
Net profit (annual): ₹1.77 Cr
P/E (TTM): 14.7×Sector 50.4×
Promoter holding: 37.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Other Announcement 1 Management Change 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Aug 2026 17:25 IST BSE

Financial Results

Sandu Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY

Sandu Pharmaceuticals Ltd reported revenue from operations of ₹16.4 Cr (-1.8% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q1 FY27.

Key figure: Net profit ₹0.2 Cr · +0.0% YoY

Open full results → Read the filing ↗

5 May 2026 18:04 IST BSE

Financial Results

Sandu Pharmaceuticals Q4 FY26 Results: Net Profit ₹0 Cr

Sandu Pharmaceuticals Ltd reported revenue from operations of ₹16.9 Cr (+19.9% YoY) and net profit of ₹0 Cr for Q4 FY26.

Key figure: Net profit ₹0 Cr

Open full results → Read the filing ↗